Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MULTI-OCTAVE
NCT01641367Phase 4Completed
- Start
- Feb 2013
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of raltegravir, darunavir, etravirine in human immunodeficiency virus type 1 infection (HIV-1). Started Feb 2013; status: completed.
02
Drugs
raltegravirdarunaviretravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01641367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641367.